Localisation of [131I]MIBG in nude mice bearing SK-N-SH human neuroblastoma xenografts: effect of specific activity.

por Vaidyanathan, G., Friedman, H. S., Keir, S. T., Zalutsky, M. R.
Publicado 1996

Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcoma.

por Castellino, S. M., Friedman, H. S., Elion, G. B., Ong, E. T., Marcelli, S. L., Page, R., Bigner, D. D., Dewhirst, M. W.
Publicado 1995

Mismatch repair deficiency: a temozolomide resistance factor in medulloblastoma cell lines that is uncommon in primary medulloblastoma tumours

por von Bueren, A O, Bacolod, M D, Hagel, C, Heinimann, K, Fedier, A, Kordes, U, Pietsch, T, Koster, J, Grotzer, M A, Friedman, H S, Marra, G, Kool, M, Rutkowski, S
Publicado 2012

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs

por Ashley, D M, Riffkin, C D, Lovric, M M, Mikeska, T, Dobrovic, A, Maxwell, J A, Friedman, H S, Drummond, K J, Kaye, A H, Gan, H K, Johns, T G, Hawkins, C J
Publicado 2008

In vitro sensitivity testing of minimally passaged and uncultured gliomas with TRAIL and/or chemotherapy drugs

por Ashley, D M, Riffkin, C D, Lovric, M M, Mikeska, T, Dobrovic, A, Maxwell, J A, Friedman, H S, Drummond, K J, Kaye, A H, Gan, H K, Johns, T G, Hawkins, C J
Publicado 2009

Metronomic chemotherapy with daily, oral etoposide plus bevacizumab for recurrent malignant glioma: a phase II study

por Reardon, D A, Desjardins, A, Vredenburgh, J J, Gururangan, S, Sampson, J H, Sathornsumetee, S, McLendon, R E, Herndon, J E, Marcello, J E, Norfleet, J, Friedman, A H, Bigner, D D, Friedman, H S
Publicado 2009

Bevacizumab continuation beyond initial bevacizumab progression among recurrent glioblastoma patients

por Reardon, D A, Herndon, J E, Peters, K B, Desjardins, A, Coan, A, Lou, E, Sumrall, A L, Turner, S, Lipp, E S, Sathornsumetee, S, Rich, J N, Sampson, J H, Friedman, A H, Boulton, S T, Bigner, D D, Friedman, H S, Vredenburgh, J J
Publicado 2012

A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse

por Yung, W K A, Albright, R E, Olson, J, Fredericks, R, Fink, K, Prados, M D, Brada, M, Spence, A, Hohl, R J, Shapiro, W, Glantz, M, Greenberg, H, Selker, R G, Vick, N A, Rampling, R, Friedman, H, Phillips, P, Bruner, J, Yue, N, Osoba, D, Zaknoen, S, Levin, V A
Publicado 2000